The Janus Corner

groupview

Abstract
Pharmacognosy Communications,2018,8,1,54-55.
Published:January 2018
Type:Janus Corner

The Janus Corner

Ian Edwin Cock

School of Natural Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.

Environmental Futures Centre, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.

Abstract:

Cannabis sativa is a plant rich in bioactive secondary compounds including terpenoids, flavonoids and a diversity of cannabanoids. Whilst C. sativa is best known for its psychotropic effects, it also has long been used in folk medicine for a wide variety of therapeutic purposes. However, the anticancer effects of this plant remain relatively unexplored. A recent study has highlighted the potential of C. sativa and isolated cannabinoids against a large panel of cancer cells. Interestingly, the cannabinoids acted via cannabinoid receptors as well as via nonspecific pathways to induce apoptosis in cancer cells, whilst at the same time protecting normal cells.1 Notably, the cannabinoids also displayed potent anticancer activity against tumours which were highly resistant to conventional chemotherapies. Furthermore, several studies have also reported that cannabinoids can function as “sensitisers”, increasing the efficacy of some conventional cancer therapies. Read more. . . 

Keywords:Janus Corner

Cite This Article

Vancouver Style :: Cock IEdwin. The Janus Corner. Pharmacognosy Communications. 2018;8(1):54-55.  (223.29 KB)
MLA Style: Cock IEdwin. The Janus Corner. Pharmacognosy Communications. 2018;8(1):54-55.  (223.29 KB)
CSE Style: Cock IEdwin. The Janus Corner. Pharmacognosy Communications. 2018;8(1):54-55.  (223.29 KB)
APA Style: Cock IEdwin. The Janus Corner. Pharmacognosy Communications. 2018;8(1):54-55.  (223.29 KB)

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.